chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt was sitting in the 15 min waiting area after getting his vaccination. Pt stated that he began to feel dizzy. Pt presented pale and diaphoretic. Pt's states that this happens when he donates blood. Pt was wheeled to the cot. Pt was seated on the cot. Pt states that he feels better when laying supine. Pt's vitals are normal. Pt states he is no longer dizzy and only feels fatigued. Pt's skin is now warm pink and dry. Pt is now able to stand. PT refused transport to hospital.
Client was assessed by EMS and Lead nurse when in the "recovery area" of the parking lot, with shortness of breath, left sided chest pain that comes and goes, metallic taste and flush skin. after receiving her first Pfizer vaccination. a pulse oximeter was placed on the client with a reading of 98% O2 sat and a pulse of 88. No abnormal lung sounds noted on oscillation. Client indicated that she has a history of anxiety, not had never had a reaction "like this" after any vaccination.  Client has a history of allergy to penicillin and Keflex. Client reassured and coached on steady, slow breathing. Client received 25mg Diphenhydramine HCL and . Client indicated that she was feeling "some better". Client reassured and instructed to not leave til symptoms had dissipated.        Client encouraged to call if anything else was needed and to take a Benadryl ahead of time if she is nervous about her second dose.
Patient works in the healthcare setting with a patient-facing job.  Pt. reports receiving the 2nd dose of the Pfizer COVID19 vaccine on 2/4/21.  Pt. reports COVID like symptoms beginning 4/26/21, testing 4/28/21 and receiving a COVID positive test result.
This spontaneous report was received from a nurse regarding unspecified patients of unknown age and gender. Information regarding the pertinent medical history, drug reactions or allergies and concomitant therapies were not provided. On unspecified dates, the patients were vaccinated with improperly stored doses of ROTATEQ injection (lot # L020865, Expiration date 09-FEB-2017; lot # M012495, Expiration date 09-OCT-2017; lot # L033548, Expiration date 14-MAY-2017) (exact dose and route of administration were not reported). The administered doses experienced a temperature excursion of 46.8 degree Fahrenheit for 6 hours and 53 minutes and 33.2 degree Fahrenheit for 27 minutes. There was no previous exposures and no data logger. No adverse effects were reported. This is one of the two reports received from the same reporter. Additional information has been requested.
Pain under left arm in Armpit area; left chest was really hot; lots of discomfort; lymph node was swollen; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Apr2021 (at the age of 39-years-old), as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included unspecified birth control medications from unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Mar2021 at 09:30 (at the age of 39-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 08:00, the patient experienced pain under left arm in armpit area, lymph node was swollen, left chest was really hot and lots of discomfort. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event pain under left arm in armpit area,  lymph node was swollen, left chest was really hot and lots of discomfort was not recovered at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Flattening of the skull from positioning; This spontaneous report was received from a medical assistant referring to a currently 10-weeks-old female patient.  Information regarding the patient's concurrent conditions or concomitant medications was not provided. The patient's medical history included growth restriction with a birth weight of 2.49 Kg.     On 15-SEP-2021 the patient was vaccinated with hepatitis B vaccine (recombinant) (manufacturer unknown) for prophylaxis (dose, route of administration, vaccination scheme frequency, anatomical location, lot number and expiration date were not reported).   On an unspecified date in 2021, the patient experienced flattening of the skull from positioning (acquired plagiocephaly). On 17-NOV-2021 the patient was administered vaccines with temperature excursion (captured in # 2111USA006585).  The outcome of the event acquired plagiocephaly and the causal relationship between the event and therapy with hepatitis B vaccine (recombinant) (manufacturer unknown) were not reported.; Sender's Comments:  US-009507513-2111USA006585:
Left intracerebral brain hemorrhage; Right hemiparesis; His platelets were 46; Systolic blood pressure 220; only responsive to touch and pain; Unresponsive; This is a spontaneous report from a non-contactable healthcare professional. A 65-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 03May2021 (Batch/Lot number was not reported) as 2nd dose, single for Covid-19 immunisation. Medical history included hypertension. Concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 for COVID-19 immunization. On 04May2021, the patient was found unresponsive by family, taken to Emergency department where left intracerebral brain hemorrhage was diagnosed.  His platelets were 46 and systolic blood pressure 220.  He has right hemiparesis and is only responsive to touch and pain. He is currently on hospice. The patient was hospitalized for 3 days and received platelet transfusion. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Based on available information and known drug profile it  is unlikely  that the reported events were causally related to bnt162b2 .  The patient's history of hypertension is a risk factor for the reported left intracerebral brain hemorrhage and. blood pressure systolic increased.  Case will be reassessed if additional information is received
soreness at the injection site; chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness at the injection site) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (soreness at the injection site) and CHILLS (chills). At the time of the report, VACCINATION SITE PAIN (soreness at the injection site) and CHILLS (chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication of the patient was not reported.   The patient had not yet received the second dose of the Moderna COVID-19 vaccine. Upon finding out, it was more than 36 days since her first dose and the patient felt it was a priority to schedule her second dose of the Moderna COVID-19 vaccine.  No treatment information was provided by the reporter.   Reporter did not allow further contact
extreme chills, nausea, chest pain, shortness of breath, fever of 104.3 that would only come down to 103 with alternating Tylenol and Ibuprofen, body aches, lasted 3 days
extreme shortness of breath/could not roll over in bed without being out breath/walk 5 ft without being out of breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (extreme shortness of breath/could not roll over in bed without being out breath/walk 5 ft without being out of breath) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     Concomitant products included PREDNISONE and ALENDRONIC ACID for an unknown indication.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (extreme shortness of breath/could not roll over in bed without being out breath/walk 5 ft without being out of breath). At the time of the report, DYSPNOEA (extreme shortness of breath/could not roll over in bed without being out breath/walk 5 ft without being out of breath) had not resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment information was not provided.  Reporter description of events:  Approximately 36 hours to 48 hours after 2nd Moderna Covid-19 vaccine, caller started getting shortness of breath. The shortness of breath got increasingly worse until 6 days after vaccine. On the 6th day he thought he was going to die, he could not roll over in bed without being out breath or walk 5 ft without being out of breath. On the 7th day post vaccine he felt a little better. Today is the 8th day and he feels the same as the 7th day.
Information has been received from a registered nurse concerning a 48 year old male with asthma and no known allergies. On 10/13/05 the pt was vaccinated IM with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 650453/0791P). Concomitant therapy included unspecified therapy two unnamed inhalers. On 10/14/05 the pt developed a localized reaction of arm with swelling, redness an skin was warm to touch. The pt was treated with diphenhydramine hydrochloride Benadryl. It was reported that it was unknown if he received vaccine in the past. The pt sought unspecified medical attention. At the time of this report, the outcome of the events were unknown. Additional information has been requested.
Myalgia, Fever, chills Narrative:  Temp, chills, myalgia; improves with ibuprofen; recovered.
Body aches; Extreme body chills; Rash at injection site; This is a spontaneous report from a contactable other health professional (patient). A 27-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot number: EN6200) via an unspecified route of administration, administered in arm left on 22Feb2021 12:00 (age at the time of vaccination was 27 years) as dose 2, single for COVID-19 immunisation at a health clinic. The patient's medical history was not reported. The patient was not pregnant at the time of vaccination. There were no known allergies. There was no other vaccine in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient not been tested for COVID-19. The patient's concomitant medications included Vitamin D3, calcium carbonate/ calcium gluconate/ magnesium gluconate/ magnesium oxide/ zinc citrate/ zinc oxide (CALCIUM MAGNESIUM AND ZINC) and probiotic, all drugs received within 2 weeks of vaccination. The patient took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot number: EL9264) via an unspecified route of administration, administered in left arm on 03Feb2021 13:15 (age at the time of vaccination was 27 years) as dose 1, single for covid-19 immunisation at school or student health clinic. On 22Feb2021, at 22:30, the patient had body aches, extreme body chills and rash at injection site after injection. The patient was not received treatment for adverse events. The outcome of events was not recovered.  Follow-up attempts are completed. No further information is expected.
immediate fatigue after 2nd shot, followed by flu-like body aches, loss of appetite for food and alcohol (wine).  No fever.  Felt fine the next morning, but got fatigued about 1/3 mile into a 1 1/2 mile walk and returned home.  Napped off and on throughout the day.   No appetite for dinner, though had a good breakfast and lunch.  Felt progressively better for the next few days.  Walked more (2 to 5 miles) but felt uncharacteristically tired afterwards.  Little appetite  for dinner, but force myself to eat something.  Things have gotten worse in the last couple of days ( 4-7 days after shot).  Get chills and get fatigued easily (e.g., doing laundry, making the bed). Take several naps per day (unlike me). Not trying to take walks.
It started 3-7 days after the booster. I still have pain. I can still feel where I got the shot. It goes from the top of my shoulder to my elbow in my left arm. It is pretty constant. It feels kind of like an electrical current running through my arm.
Information has been received from a pharmacist concerning her 76 year old mother, with a recent diagnosis of mycobacterium avium intracellulare lymphadenitis (MAI/MAC), who on 29-JAN-2008 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. On 29-JAN-2008, the patient experienced redness and swelling at the injection site. The patient visited another country in November 2007, and in December 2007 saw her cardiologist and was diagnosed with MAI/MAC infection which may have been present at the time of the pneumococcal 23v polysaccharide vaccine. On 02-FEB-2008, the patient recovered. No further information is available.
son contract covid-19 7/26 at summer camp  patient admitted 8/6, ahrf saturating 48% on RA placed on 50L/100% high flow o2 and admitted to ICU  started on remdesivir, dexamethasone, and tocilizumab given within 24h of hospital admission
Numbness and tingling in the left hand finger. Initial BP 172/63, pulse 71, 99% O2 sat. Patient went to the ED.
9/16/19: Patient noted fatigue and nausea, a tingling sensation across the abdominal wall which  improved within 48 hours.  Left sided headache, worse on 9/16 evening-gradually resolved within 48 hours.  Insomnia.  Nocturia and frequency developed on the night of 9/18/19.  Symptoms resolved spontaneously on 9/22/19.  She experienced transient increas in her chronic peripheral neuropathy which resolved back to baseline by 9/23/19
No adverse reactions occurred. Patient was administered 1 dose of spoiled vaccine. Vial was an open vial left in cooler on 8/4/2021 and was not discarded at end of day. It was misidentified on 8/6/2021 as an active and good vial and used to vaccinate 3 patients with spoiled doses.
Patient received his booster vaccine and had zero immediate reaction. On 12/11/2021, he developed severe itching on both feet. Saw his PCP soon after and started taking Xyzal daily. Since starting, the itching has been manageable. Though if he goes without, his whole body becomes painfully itchy.
At approximately 20 min following dose administration noted left neck pain subsequently developed perioral paresthesia, chest tightness.  No stridor, drooling, wheezing or nausea/vomiting.  Vitals were stable.  Patient states that she took Claritin prior to her vaccination.  No medications since symptoms started.  States symptoms have improved in all told lasted approximately 30 min.
Initially with sore right upper arm, soon followed by numbness and tingling down the entire arm. In 2 to 3 days soreness resolved but numbness persisted. Patient also notes increased fatigue to right arm.
Initial information received on 19-Nov-2018 regarding an unsolicited valid non-serious case received from a health care professional. This case involves a patient (age and gender not reported) who received vaccination with 0.5 ml FLUZONE QUADRIVALENT (batch number UT6290MA, expiry date 30 June 2019, route and site of administration were not reported) on 18 Nov 2018. Patient had not received concomitant. It was a case of actual medication error due to Incorrect product storage as patient received FLUZONE QUAD after it was exposed to a high of 33.54 degrees Celsius. It was not reported if any adverse event was occurred. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. Documents held by sender: none.
Onset of diarrhea within 24 hours. No fever, rash or vomiting.
Patient received two doses of Menveo in one appointment; This non-serious case was reported by a nurse via call center representative and described the occurrence of overdose in a 16-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number M23G5, expiry date 30-NOV-2024) for prophylaxis.   On 24-AUG-2023, the patient received the 3rd dose of Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced overdose (Verbatim: Patient received two doses of Menveo in one appointment).  The outcome of the overdose was unknown.   Additional Information: GSK Receipt Date: 24-AUG-2023 The reporter reported that the patient received two doses of Menveo vaccine in one appointment which led to overdose. The reporter wanted to know how to proceed. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up.
received a phone call from the daughter of the patient. On 01/21/2021, patient came in and got his first Covid Vaccination. 3 days after the vaccination, the patient experienced really bad diarrhea, and was sleeping for 22 hours a day. 2 weeks later he perked up a little bit. On 02/23/2021, patient received his booster. Daughter states that 2 days later, patient shut down completely, not eating or drinking. The patient ended up passing away on 03/05/2021.
Information has been received from a registered nurse concerning a child who on 16MAY2000 was vaccinated with a dose of varicella virus vaccine live. On 16MAY2000 concomitant therapy included diphtheria toxoid/pertussis vaccineteta, poliovirus vaccine and measles virus vaccine live+mumps virus vaccine live+rubella virus vaccine live, respectively. Subsequently , the child developed a mild case of chickenpox. It was noted that there was no hospitalization or complications", no treatment was required and patients were not seen by the nurse , but were reported by parents as explanation of an absence. It was also noted that th child was part of six cases that took place over the last school year from 9/02 to present. Unspecified medical attention was sought. There was no product quality complaint reported. At the time of this report the child was 9 years of age. The nurse also reported that five other children developed mild chickenpox. Additional information has been requested.
c/o heart palpitations every noc since vax; seen by MD 19MAY93; Findings no strong correlation between sx & vax but advised to omit subsequent doses of vax;
accidental overdose is reported in a pt receiving fluogen; pt has a hx of alzheimer's disease; this is 1 of 30 cases reported from this site; No adverse effects noted;
No adverse reaction, treatment, etc.  Patient claims to have gotten the shot on the above time and date, however our system shows it as cancelled.  Being that the shot was 3 months ago much of the evidence and memory of the interaction has past.  Since our system shows as cancelled nothing got reported to the state registry, however some evidence exists to support the patients claim of having the shot and it possibly getting accidentally cancelled on our end.
This spontaneous report as received from a health professional refers to a patient of unknown age and gender. On 10-DEC-2014, the patient was vaccinated with a dose of improperly stored ROTATEQ (lot #, expiration date, dose, route and site of administration were not reported). No adverse effects was reported. This is one of several reports from the same reporter. Additional information has been requested.
No Additional AE; Vaccine stored improperly and experience a supported temperature excursion; This spontaneous report was received from a Medical Assistant and refers to a patient of unknown age and gender.  The patient's medical history, concurrent conditions, and concomitant therapies were not provided.  On 11-JUL-2023, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) injection (recombinant Human albumin), lot #W038813 verified ad valid after internal review, expiration date: 04-JUN-2024, administered for prophylaxis (anatomical location, strength, and route of administration were not provided). The vaccine was stored improperly and experienced a supported temperature excursion: temperature/ time frame: 12.43 F for 11 hours 30 minutes; 18.43 F for 2 hours 20 minutes. No patient side effects reported. No additional adverse event was provided.
Information has been received from a certified medical assistant concerning a female (age not reported) who on an unspecified date was vaccinated with a dose of Pneumovax 23. Subsequently the pateint developed cellulitis. The pateint sought unspecified medical attention. It was unknown of the patient recovered. This is one of two reports from the same source. Additional information has been requested.
Started having Stiff neck and Stiff shoulder since 4/22/2021. Unable to work or manage pain. Not able to sleep because of pain and unable to find a posture that can help relive pain. Was taking Advil and Tylenol continuously, but of no use. Started taking the TiZANdine 2mg from 4/23/2021 but no change in pain. Been to Physician's office on 4/27/2021. Doctor tried to change prescription to GABAPENTIN 100mg.
Pfizer 8/6/21 and 8/27/21. Positive on 1/18/22
Since I received my first Anthrax shot all of my joints ache. It takes me approximately 10 minutes in the morning to be able to put weight on my ankles. All of my joints ache all of the time.
Right leg is painful and swollen-3cm by 3cm--red/round warm area lateral side of thigh. Located in SQ of skin, no mass. Child says "ow" when touched on any area of RT as well as LT leg. Child is limping/favoring LT leg. Treatment; IBU, warm moist heat to area.  RTC PRN if symptoms worsen.
headache; This spontaneous case was reported by a patient family member or friend and describes the occurrence of HEADACHE (headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Concurrent medical conditions included Asthma.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) had resolved.            No concomitant medication information was provided.  No treatment medication were provided.   Reporter did not allow further contact